Search Results

Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.

• Authors : Talmon, Maria; Percio, Marcella; Obeng, Joyce Afrakoma

• Source: PLoS ONE. March 6, 2023, Vol. 18 Issue 3, e0282564.

Record details

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.

• Authors : Temmoku, Jumpei; Miyata, Masayuki; Suzuki, Eiji

• Source: PLoS ONE. September 19, 2022, Vol. 17 Issue 9, e0274775.

Record details

Intranasal administration of abatacept enhances IL-35.sup.+ and IL-10.sup.+ producing Bregs in lung tissues of ovalbumin-sensitized asthmatic mice model.

• Authors : Alenazy, Maha Fahad; Sharif-Askari, Fatemeh Saheb; El-Wetidy, Mohammed S.

• Source: PLoS ONE. September 6, 2022, Vol. 17 Issue 9, e0271689.

Record details

Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis.

• Authors : Derambure, Céline; Dzangue-Tchoupou, Gaelle; D'Agostino, Maria Antonietta

• Source: PLoS ONE. August 6, 2020, Vol. 15 Issue 8, e0237143.

Record details

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.

• Authors : Huoponen, Saara; Aaltonen, Kalle J.; Viikinkoski, Jaana

• Source: PLoS ONE. July 24, 2019, Vol. 14 Issue 7, e0220142.

Record details

Coya Therapeutics, Inc. Announces an Agreement with Dr. Reddy's Laboratories, Ltd. to License its proposed biosimilar Abatacept for the Development and Commercialization of COYA 302.

• Source: ENP Newswire. March 21, 2023.

Record details

Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.

• Authors : Balandraud, Nathalie; Texier, Gaetan; Massy, Emmanuel

• Source: PLoS ONE. February 15, 2017, Vol. 12 Issue 2, e0171623.

Record details

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research.

• Authors : Maeda, Shinji; Osaga, Satoshi; Maeda, Tomoyo

• Source: PLoS ONE. November 20, 2019, Vol. 14 Issue 11, e0215192.

Record details

Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy.

• Authors : Norlin, Jenny; Nielsen Fink, Lisbeth; Helding Kvist, Peter

• Source: PLoS ONE. April 7, 2016, Vol. 11 Issue 4.

Record details

The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.

• Authors : Provan, Sella Aarrestad; Berg, Inger Jorid; Hammer, Hilde Berner

• Source: PLoS ONE. June 26, 2015, Vol. 10 Issue 6.

Record details